Cell-like features imprinted in the physical nano- and micro-topography of the environment modify the responses to anti-cancer drugs of endometrial cancer cells
- 14 February 2017
- journal article
- research article
- Published by IOP Publishing in Biofabrication
- Vol. 9 (1) , 015017
Abstract
Topographical features of cells at nanometre resolution were fabricated in polystyrene. The study investigated the effect of physical topography on the response of cancer cells to the common anticancer drugs, paclitaxel and doxorubicin. Human endometrial cancer cells (Ishikawa) were incubated on substrates containing cell-like features that had been fabricated using our bioimprint methodology to create moulds of cells with positive (convex) and negative (concave) topography. Control cultures were performed on flat substrates. Effects of the drugs on caspase-3 expression, proliferating nuclear antigen (PCNA) expression, cell number and vascular endothelial growth factor (VEGF) secretion were determined. Results revealed that the topography influenced the cell responses in a drug-dependent manner i.e. paclitaxel effects were sensitive to topography differently to those of doxorubicin. In addition, function signalling pathways were sensitive to the detailed topography i.e. positive imprint and negative imprint induced distinct response patterns. The results in this study show for the first time that a culture surface with cell-like topography, that has both nano- and micro-resolution, influences endometrial cancer cell responses to chemotherapy drugs. The effects are dependent on the topography and also on the chemotherapy drug. In particular, the platforms described have potential to provide substrates with high physical relevancy on which to undertake preclinical testing of new drugs. The method also allows for use of different cell types to provide cell-specific topography. The results imply that physical architecture of the cancer cell environment may be a suitable prospective target to enhance clinical activity of traditional drugs. Additionally or alternatively we provide compelling support for the notion that understanding the physical component of the nano- and micro-environment may encourage a redirection of drug development. Further, our observation that the cells distinguish between the different cell-like topographies (positive and negative bioimprints) indicates that a realistic topography is advantageous as growth platforms in experiment design.Keywords
Funding Information
- The Marsden Fund (Post doctoral fellowship and materi)
- New Zealand Cancer Society, Canterbury-West Coast Division (Materials)
- MacDiarmid Institute for Advanced Materials and Nanotechnology (PhD fellowship and materials)
This publication has 58 references indexed in Scilit:
- A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)Annals of Oncology, 2015
- Paracrine control of tissue regeneration and cell proliferation by Caspase-3Cell Death & Disease, 2013
- Low dose chemotherapeutic drugs without overt cytotoxic effects decrease the secretion of VEGF by cultured human tumor cells: A tentative relationship between drug type and tumor cell type responseCancer Biomarkers, 2013
- Fibroblast Growth Factor Receptor Inhibition Synergizes With Paclitaxel and Doxorubicin in Endometrial Cancer CellsInternational Journal of Gynecological Cancer, 2012
- Doxorubicin induces the DNA damage response in cultured human mesenchymal stem cellsInternational Journal of Hematology, 2012
- The resistance of intracellular mediators to doxorubicin and cisplatin are distinct in 3D and 2D endometrial cancerJournal of Translational Medicine, 2012
- Expression patterns and cell cycle profiles of PCNA, MCM6, cyclin D1, cyclin A2, cyclin B1, and phosphorylated histone H3 in the developing mouse retinaDevelopmental Dynamics, 2008
- Rho GTPase signalling pathways in the morphological changes associated with apoptosisCell Death & Differentiation, 2002
- Cell Adhesion Mediated Drug Resistance (CAM-DR): Role of Integrins and Resistance to Apoptosis in Human Myeloma Cell LinesBlood, 1999
- Geometric Control of Cell Life and DeathScience, 1997